Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use

Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use

US Patent 7135186 · Granted Nov 14, 2006

Estimated economic value: $20,051,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Coagulation factor X polypeptides with modified activation properties2016
Coagulation factor X polypeptides with modified activation properties2016
Modified vitamin K dependent polypeptides2014
Human procalcitonin and the preparation and use thereof2008
Use of plasma proteins concentrates containing VWF with a high proportion of hig2008
Retrovirus from the HIV type O and its use (MVP-2901/94)2005
Immunoreactive regions of glycoprotein gpII of varicella zoster virus (VZV)2005
Immunoreactive regions of glycoprotein gpII of varicella zoster virus (VZV)2005
Immunoreactive regions of glycoprotein gpII of varicella zoster virus (VZV)2005
Immunoreactive regions of glycoprotein gpII of varicella zoster virus (VZV)2005
Immunoreactive regions of glycoprotein gpII of varicella zoster virus (VZV)2005
Human procalcitonin and the preparation and use thereof2005